feed,title,long_url,short_url
Benzinga,Bristol Myers Inks $1.6B Licensing Agreement For Agenus' Bispecific Antibody Program In Solid Tumors,https://benzinga.com/general/biotech/21/05/21173037/bristol-myers-inks-1-6b-licensing-agreement-for-agenus-bispecific-antibody-program-in-solid-tumor,https://j.mp/3bSHju7
